NCT00783601已完成2 期
A Multicenter, Randomized, Double Blind, Crossover Study Comparing the Effect of MK0524 With Placebo and Concomitant Administration of MK0524 Plus Montelukast in Adult Patients With Chronic Asthma
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 130
- 主要终点
- To demonstrate benefits of MK0524 compared with placebo on Forced Expiratory Volume in 1 second (FEV1)
研究概览
简要总结
The purpose of the study is to demonstrate the benefit of MK0524 compared to placebo in patients with chronic asthma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Has symptoms of chronic asthma (shortness of breath, wheezing, chest tightness, etc.) for at least 1 year
- •Nonsmoker for at least 1 year with a smoking history of no more than 7 pack-years (i.e., 1 pack per day for 7 years)
排除标准
- •Any clinically significant disease of heart, intestinal, kidney, liver, lung or uncontrolled blood pressure
- •Any surgery within 4 weeks prior to Visit 1
- •Patient is intending to move or vacation for more than 5 days during the study
- •Patient is pregnant or breast-feeding
结局指标
主要结局
To demonstrate benefits of MK0524 compared with placebo on Forced Expiratory Volume in 1 second (FEV1)
时间窗: Last 2 weeks of each treatment period
次要结局
- To determine the benefits of MK0524 as compared with placebo on the key secondary endpoints (Daytime & Nighttime Asthma Symptoms scores(Last 2 weeks of each treatment period)
研究者
相似试验
已完成
3 期
Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)AsthmaNCT00284856Organon and Co1,640
已完成
2 期
Endpoint Validation Study (0524A-015)FlushingNCT00533676Merck Sharp & Dohme LLC165
已完成
2 期
Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)HypertensionNCT00274716Merck Sharp & Dohme LLC249
已完成
3 期
Effect of MK0524A on Cholesterol Levels (0524A-048)HypercholesterolemiaHyperlipidemiaNCT00536510Merck Sharp & Dohme LLC646
已完成
3 期
Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)MigraineNCT00432237Merck Sharp & Dohme LLC1,703